Thomas Joseph Hannan

Principal investigator.

Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.1MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Career record

Federal awards and patents by year

20152024
AwardsPatents
Federal awards as principal investigator

10 awards · $6.1M

DateAgencyAwardAmountCompany
Jan 31, 2024NIHSBIR Phase I
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
$300KFIMBRION THERAPEUTICS INC
Dec 7, 2023NIHSBIR Phase II
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$995KFIMBRION THERAPEUTICS INC
Mar 8, 2023NIHSBIR Phase I
Thiazolino-Pyridone Compounds as Novel Drugs for Tuberculosis
$300KFIMBRION THERAPEUTICS INC
Nov 7, 2022NIHSBIR Phase II
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$998KFIMBRION THERAPEUTICS INC
Dec 8, 2021NIHSBIR Phase II
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$1.0MFIMBRION THERAPEUTICS INC
Nov 30, 2020NIHSBIR Phase I
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$293KFIMBRION THERAPEUTICS INC
Dec 13, 2019NIHSBIR Phase I
Heterocyclic Inhibitors of QcrB as Novel Drugs for Tuberculosis
$300KFIMBRION THERAPEUTICS INC
Feb 7, 2018NIHSBIR Phase II
Anti-Virulence FimH Inhibitors for the Treatment and Prevention of UTIs
$725KFIMBRION THERAPEUTICS INC
Mar 10, 2017NIHSBIR Phase II
Anti-Virulence FimH Inhibitors for the Treatment and Prevention of UTIs
$901KFIMBRION THERAPEUTICS INC
Jun 16, 2015NIHSBIR Phase I
Anti-virulence FimH inhibitors for the treatment and prevention of UTIs
$269KFIMBRION THERAPEUTICS INC
Among 4,078 researchers in Biotech

Peer ranks

Federal funding#181
Awards as PI#128
Patents#273
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.